Johns Hopkins University and Mt. Sinai Hospital of Toronto Honored For Innovative Use of Health Information and Technology to

    Johns Hopkins University and Mt. Sinai Hospital of Toronto Honored For
 Innovative Use of Health Information and Technology to Improve Patient Care

  PR Newswire

  PHILADELPHIA, March 4, 2013

PHILADELPHIA, March 4, 2013 /PRNewswire/ --

Elsevier 'Key Innovator Award' recipients to attend HIMSS13 and present their
                       winning programs at booth #6129

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, has recognized Johns Hopkins University and
Mt. Sinai Hospital with the first annual Key Innovator Award for each
organization's innovative use of information and technology to save lives and
improve patient care.

Each winning organization received a $10,000 grant and trip to the Healthcare
Information Management and Systems Society (HIMSS13) annual meeting in New
Orleans, March 3-7. Elsevier's ClinicalKey , a clinical insight engine that
provides the most current and clinically relevant evidence-based answers,
sponsored the award.

"We developed the Key Innovator Award to raise awareness of health IT projects
that have significantly contributed to improving patient outcomes and
exemplify the true meaning of innovation in healthcare," said Jay Katzen,
president of Elsevier's clinical solutions business. "These winning
organizations have created programs that not only improve patient care but
exemplify how effectively leveraging technology and information can
revolutionize standards of quality healthcare."

The Key Innovator Award recipients will present their winning projects at
HIMSS13 at Elsevier's booth (#6129). These winners' programs are:

  *Mood 24/7 , invented by Dr. Adam Kaplin, an Assistant Professor in the
    Departments of Psychiatry and Neurology at Johns Hopkins University School
    of Medicine, is a web-based program that utilizes cell phones and texting
    technology to send automatic daily texts to a patient at a specified time,
    asking the patient to record his/her mood. Mood 24/7 was developed to
    support psychologists' ability to capture their patients' moods over time,
    as patients often forget to maintain the written record between office
    visits.
  *The Evidence-Based Medicine Algorithm , created by Sandra Kendall,
    Director of Library Services at Mount Sinai Hospital, was developed to
    demonstrate how the power of information can improve clinicians' work,
    thus improving patient care. She grouped different databases into tiers,
    assisting practitioners in choosing the best evidence-based resources
    available. Kendall also recently created a Library Value Study designed to
    demonstrate how the library has contributed to better medical education
    and clinical research, and to seek input into how the library can continue
    to contribute to better patient care by supporting clinical research in
    innovative ways.

"On behalf of the team at Mt. Sinai in Toronto, we are very excited to receive
this award from Elsevier," Kendall said. "We see tremendous value in the
evidence-based medicine project, as it allows our physicians to fully leverage
the power of our resources in ways that they haven't done before to directly
influence patient care delivery."

Elsevier will host a Meet & Greet for the Key Innovator Award winners at
HIMSS13. To learn more about their projects, please visit booth #6129 on:

  *Monday, March 4, 2-3 p.m.- Johns Hopkins
  *Tuesday, March 5, 10:30-11:30 a.m. - Mount Sinai Hospital

In addition to recognizing the Key Innovator Award winners, Elsevier will
demonstrate its integrated clinical decision support (CDS) and clinical
reference solutions that help healthcare providers and payers achieve the
triple aim of clinical, operational and financial excellence.

Learn more about Elsevier, ClinicalKey and the Key Innovator Award honorees at
HIMSS13, March 3-7, in New Orleans at booth #6129. For a full schedule of
Elsevier product demonstrations and presentations at HIMSS13, please visit
http://www.clinicaldecisionsupport.com/himss13 .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
provider of professional information solutions in the Science, Medical, Legal
and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and
Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Christopher Capot Director, Corporate Relations Elsevier
+1-212-633-3164 c.capot@elsevier.com